Immatics (IMTX) Other Working Capital Changes (2019 - 2025)
Immatics (IMTX) reported Other Working Capital Changes of -$5.3 million for Q4 2025, down 870.14% on a YoY basis from $688175.4 in Q4 2024, and down 254.73% sequentially from -$1.5 million in Q3 2025.
Immatics (IMTX) Other Working Capital Changes (2019 - 2025) Analysis & Trends
Immatics (IMTX) has 7 years of Other Working Capital Changes data on file, last reported at -$5.3 million in Q4 2025.
- For the quarter ending Q4 2025, Other Working Capital Changes fell 870.14% year-over-year to -$5.3 million; the trailing twelve-month figure through Dec 2025 stood at -$7.1 million (down 1017.67% YoY), and the FY2025 full-year result was -$6.9 million, down 977.02% from the prior year.
- Other Working Capital Changes slipped to -$5.3 million in Q4 2025, from -$1.5 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $729681.4 in Q4 2020 to a low of -$7.1 million in Q2 2022.
- A 5-year average of -$993353.4 and a median of -$263749.4 in 2022 frame the typical range for Other Working Capital Changes.
- Across the five-year window, Other Working Capital Changes soared 453.58% in 2021 and plunged 870.14% in 2025, its largest moves.
- Tracing IMTX's Other Working Capital Changes over 5 years: stood at -$367302.8 in 2021, then slumped by 1486.05% to -$5.8 million in 2022, then soared by 182.19% to $4.8 million in 2023, then plunged by 85.63% to $688175.4 in 2024, then sank by 870.14% to -$5.3 million in 2025.
- Business Quant data shows IMTX's Other Working Capital Changes at -$5.3 million in Q4 2025, -$1.5 million in Q3 2025, and -$211676.5 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Immatics | 1.14 Bn | 1.14 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.30 Mn |
| Dec 31, 2025 | -5.30 Mn |
| Dec 31, 2025 | -5.30 Mn |
| Sep 30, 2025 | -1.49 Mn |
| Sep 30, 2025 | -1.49 Mn |
| Sep 30, 2025 | -1.49 Mn |
| Jun 30, 2025 | -211,676.46 |
| Jun 30, 2025 | -211,676.46 |
| Jun 30, 2025 | -211,676.46 |
| Mar 31, 2025 | -94,669.60 |
| Mar 31, 2025 | -94,669.60 |
| Mar 31, 2025 | -94,669.60 |
| Dec 31, 2024 | 688,175.44 |
| Dec 31, 2024 | 688,175.44 |
| Dec 31, 2024 | 688,175.44 |
| Sep 30, 2024 | -750,083.92 |
| Sep 30, 2024 | -750,083.92 |
| Sep 30, 2024 | -750,083.92 |
| Jun 30, 2024 | -396,294.63 |
| Jun 30, 2024 | -396,294.63 |